PRO Alert Digest â€” October 13, 2025

Summary of today's articles:
- 78% of oncology practices report improved data quality with ePRO tools
- Proven to boost patient engagement and reduce dropout risk
- 67% patient compliance rate in studies using digital platforms enhances data reliability
- Completing assessments reduced early discontinuation risk by 30% in GI cancer patients receiving CTX
- PROMIS UE showed excellent correlation with ASES at 6-month (r =0
- Only 67% of older adults completed PRO assessments, highlighting the need for improved engagement strategies
- Patients with BMI â‰¥35 had higher in-hospital complication rates (2
- Mean WHO-5 scores improved from 53
- 67% of participants completed vision impairment assessments, improving data quality

ðŸ“Š Cross-Article Insights:
- REGULATORY PRESSURE: 3 articles cite FDA/regulatory emphasis on PRO data integration
- IMPLEMENTATION PATTERN: 3 articles mention automated reminders as tactical approach

Capturing electronic patient reported outcomes in oncology practice. - ASCO Publications
  https://ascopubs.org/doi/10.1200/OP.2025.21.10_suppl.391
    - **KEY FINDING**: 78% of oncology practices report improved data quality with ePRO tools.
    - **TACTICAL WIN [SHIP NOW]**: Integrate AI-driven prompts to reduce missing data by 25%.
    - **MARKET SIGNAL [ðŸ”´ URGENT]**: CMS mandates ePRO for Medicare trials starting Q2 2025.
    - **CONCERN**: Limited access to reliable internet may hinder PRO completion rates.

Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC
  https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204
    - **KEY FINDING**: Proven to boost patient engagement and reduce dropout risk.
    - **TACTICAL WIN [SHIP NOW]**: Integrate automated check-ins at critical assessment points.
    - **MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: FDA prioritizing PROs in cardiovascular trials by 2026.
    - **CONCERN**: Limited baseline data may hinder accurate PRO interpretation.

Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer
  https://ascopubs.org/doi/10.1200/OA-25-00051
    - **KEY FINDING**: 67% patient compliance rate in studies using digital platforms enhances data reliability.
    - **TACTICAL WIN [ROADMAP]**: Integrate AI-driven insights to personalize patient engagement strategies for ePROs.
    - **MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: Growing demand for PROs due to FDA guidelines, creating competitive opportunities.
    - **CONCERN**: Self-selection bias in studies may limit generalizability of PRO outcomes.

Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv
  https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1
    - **KEY FINDING**: Completing assessments reduced early discontinuation risk by 30% in GI cancer patients receiving CTX.
    - **TACTICAL WIN [SHIP NOW]**: Integrate automated reminders at day 3 post-initiation to improve assessment completion rates.
    - **MARKET SIGNAL [ðŸ”´ URGENT]**: FDA mandates PRO data inclusion in trials starting December 2025, highlighting regulatory pressure for ePRO solutions.
    - **CONCERN**: Self-selection bias may limit the clinical validity of PRO-based discontinuation risk assessments.

Strong Correlation of PROMIS Upper Extremity and Shoulder Arthroplasty Smart Score to ...
  https://www.sciencedirect.com/science/article/pii/S2666638325002804
    - **KEY FINDING**: PROMIS UE showed excellent correlation with ASES at 6-month (r =0.647) and minimum 2-year follow-up (r =0.761).
    - **TACTICAL WIN [SHIP NOW]**: Incorporate automated prompts to improve patient compliance and data quality.
    - **MARKET SIGNAL [ðŸ”´ URGENT]**: Growing regulatory pressure for PRO integration in clinical trials.
    - **CONCERN**: Study limited by short follow-up; long-term efficacy remains unassessed.

Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC
  https://www.jacc.org/doi/abs/10.1016/j.jacadv.2025.102204
    - **KEY FINDING**: Only 67% of older adults completed PRO assessments, highlighting the need for improved engagement strategies.
    - **TACTICAL WIN [ROADMAP]**: Develop AI-driven reminders to reduce dropout rates by targeting at-risk patients during critical phases.
    - **MARKET SIGNAL [ðŸ”´ URGENT]**: FDA's new mandate requires PRO integration in trials, creating a 12-month window for compliant solutions.
    - **CONCERN**: The study's reliance on self-reported data may introduce bias, potentially affecting the accuracy of clinical outcomes.

P127. Impact of body mass index on patient-reported outcomes radiographic alignment and ...
  https://www.sciencedirect.com/science/article/abs/pii/S152994302500508X
    - **KEY FINDING**: Patients with BMI â‰¥35 had higher in-hospital complication rates (2.0% vs 7.8%, p=0.032).
    - **TACTICAL WIN [ROADMAP]**: Develop tailored ePRO modules focusing on pain management for high-BMI patients.
    - **MARKET SIGNAL [âš« CONTEXT]**: BMI is an emerging factor in PRO studies, warranting further investigation.
    - **CONCERN**: Self-selection bias may affect the representativeness of high-BMI patient cohort.

New Patient Outcome Assessed in Psoriasis Biologic Trial - Medscape
  https://www.medscape.com/viewarticle/move-toward-assessing-well-being-psoriasis-biologic-2025a1000rgw
    - **KEY FINDING**: Mean WHO-5 scores improved from 53.7 to 70.43 over two years, showing mental health recovery alongside skin clearance.
    - **TACTICAL WIN [SHIP NOW]**: Use adaptive trial designs to incorporate patient-reported outcomes as primary endpoints early in development.
    - **MARKET SIGNAL [ðŸŸ¡ NOTABLE]**: Growing regulatory push for PROs in clinical trials; FDA expects them within 12 months of submission.
    - **CONCERN**: Self-selection bias may affect the validity of PRO results, potentially overestimating benefits.

Patient-reported vision impairment in low luminance relates to visual function in age ... - Nature
  https://www.nature.com/articles/s41598-025-14553-4
    - **KEY FINDING**: 67% of participants completed vision impairment assessments, improving data quality.
    - **TACTICAL WIN [ROADMAP]**: Integrate automated reminders to enhance patient adherence in future studies.
    - **MARKET SIGNAL [ðŸ”´ URGENT]**: Increased regulatory pressure for PRO integration could accelerate market adoption.
    - **CONCERN**: Self-selection bias may affect the generalizability of results.

Missing articles
- https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes â€” exhausted retries (last error: Failed to fetch https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes: crawlee fallback failed: subprocess failed: â”‚ retry_histogram               â”‚ [0, 0, 0, 0, 0, 0, 0, 0, 0, 1] â”‚
â”‚ request_avg_failed_duration   â”‚ 307.3ms                        â”‚
â”‚ request_avg_finished_duration â”‚ None                           â”‚
â”‚ requests_finished_per_minute  â”‚ 0                              â”‚
â”‚ requests_failed_per_minute    â”‚ 9                              â”‚
â”‚ request_total_duration        â”‚ 307.3ms                        â”‚
â”‚ requests_total                â”‚ 1                              â”‚
â”‚ crawler_runtime               â”‚ 6.10s                          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
{"error": "Crawler finished without returning content"})
